Cancer Immunotherapy Trials Network (U01)

Post Date

December 1st 2009

Application Due Date

February 19th 2010

Funding Opportunity Number

RFA-CA-10-007

CFDA Number(s)

93.395

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Education
Health

Eligibility Categories

Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education

Funding

• Award Range:

  $None - $None

Grant Description

Purpose. The purpose of this funding opportunity announcement (FOA) is to stimulate the conduct of early (Phase I and Phase II) clinical trials in the area of cancer immunotherapy by forming a Cancer Immunotherapy Trials Network (CITN). The emphasis is on clinical trials of high priority agents that were identified at the 2007 NCI immunotherapy agent workshop and on clinical trials using combinations of immunotherapy modalities and other agents. The CITN will support a multi-investigator team assembled to bring new immunotherapy agents to the clinic. This support will be realized through a single award for a Central Operations and Statistical Center (COSC) of the CITN. Whereas this FOA solicits applications specifically for the CITN COSC, the awardee team and their Program Directors/Principal Investigators (PDs/PIs) will provide overall leadership and statistical and protocol coordinator support for the CITN program. COSC applicants must plan that the CITN will include the following additional elements : (1) up to 25 institutions that will conduct the clinical trials as CITN Member Sites (supported through subcontracts within the COSC award); (2) support for tumor immunology laboratories that are associated with the Member Sites to conduct standardized immunomonitoring assays and biomarker and correlative studies related to the clinical trials; and (3) a data coordinating service that will be provided by a unit operated by the NCI (which remains beyond the scope of solicited applications).

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-10-007.html